Sung Lee

Directeur Financier/CFO chez CYTOKINETICS, INCORPORATED Fortune : 3 M $ au 31/05/2024

Profil

Sung H.
Lee's career history includes current and former positions as well as education.
Currently, Mr. Lee is the Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. Previously, Mr. Lee held positions at Gilead Sciences, Inc. as Vice President-Investor Relations from 2005 to 2019, Sangamo Therapeutics, Inc. as Chief Financial Officer & Executive Vice President from 2019 to 2021, MorphoSys AG as Chief Financial Officer from 2021 to 2023, and Vir Biotechnology, Inc. as Chief Financial Officer, Secretary & Executive VP from 2023 to 2024.
Mr. Lee obtained a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Irvine.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CYTOKINETICS, INCORPORATED 0,03%	31/05/2024	34 684 ( 0,03% )	2 M $	31/05/2024
VIR BIOTECHNOLOGY, INC. 0,07%	27/03/2024	100 492 ( 0,07% )	1 M $	31/05/2024

Postes actifs de Sung Lee

Sociétés	Poste	Début
CYTOKINETICS, INCORPORATED	Directeur Financier/CFO	08/05/2024

Anciens postes connus de Sung Lee

Sociétés	Poste	Fin
VIR BIOTECHNOLOGY, INC.	Directeur Financier/CFO	03/05/2024
MORPHOSYS AG	Directeur Financier/CFO	17/03/2023
SANGAMO THERAPEUTICS, INC.	Directeur Financier/CFO	01/02/2021
GILEAD SCIENCES, INC.	Investor Relations Contact	31/10/2019

Formation de Sung Lee

University of California, Irvine	Undergraduate Degree
University of Southern California	Graduate Degree